ADAMA (000553) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
22 Jan, 2026Executive summary
H1 2024 sales declined 16% year-over-year to $2.1 billion, driven by lower prices and volumes amid high competition and just-in-time purchasing trends.
Adjusted EBITDA and margins improved in Q2 and H1 2024 due to strict inventory and OPEX management, despite lower sales.
Net loss deepened in H1 2024, with reported net loss of $154 million and adjusted net loss of $71 million, despite improved cash flow.
Positive operating cash flow and free cash flow achieved through working capital and inventory management, with H1 2024 operating cash flow up $243 million year-over-year.
Transformation plan and Fight Forward initiative are underway, focusing on business quality, cost control, and portfolio differentiation.
Financial highlights
H1 2024 sales fell to $2.1 billion from $2.5 billion in H1 2023; Q2 sales dropped 16% year-over-year to $1,041 million.
Gross profit declined to $557 million, but gross margin improved to 26.5% in H1 2024.
Adjusted EBITDA for H1 2024 was $252 million (12.0% margin), with Q2 adjusted EBITDA up 7% year-over-year.
Net loss for H1 2024 was $154 million (reported) and $71 million (adjusted); operating cash flow improved significantly.
Inventory reduced by $609 million year-over-year, with inventory days at 181, the lowest in recent quarters.
Outlook and guidance
No full-year guidance provided; management remains focused on transformation, business quality, and cash flow.
Market recovery is not expected in 2025, with improvement dependent on Brazil's second-half performance.
CapEx will remain focused on essential, high-ROI projects, with further reductions planned.
Ongoing pricing pressure, high competition, and just-in-time purchasing patterns persist.
Latest events from ADAMA
- Margins and cash flow improved in Q3 2024 despite lower sales and ongoing pricing pressure.000553
Q3 20243 Feb 2026 - EBITDA and margins rose, net losses narrowed, and top-line growth returned despite price pressure.000553
Q2 202522 Dec 2025 - Returned to profit in Q1 2025 with improved margins amid ongoing market headwinds.000553
Q1 202522 Dec 2025 - Sales stable, margins up, and net loss narrowed despite persistent pricing pressure.000553
Q3 202522 Dec 2025 - Gross and EBITDA margins rose in 2024, with strong cash flow despite lower sales.000553
Q4 20243 Dec 2025